The prevalence of VKORC1 1639 G>A and CYP2C923 genotypes in patients that requiring anticoagulant therapy in Turkish population. [electronic resource]

By:

Silan, Coskun

Contributor(s):

Dogan, Omer Tamer
Silan, Fatma
Kukulguven, Fatma Mutlu
Asgun, Halil Fatih
Ozdemir, Semra
Uludag, Ahmet
Atik, Sinem
Gungor, Buket
Akdur, Seçil
Aksulu, Hakki Engin
Ozdemir, Oztürk

Producer: 20130404Description: 11017-22 p. digitalISSN:

1573-4978

Subject(s):

Adult
Aged
Aged, 80 and over
Alleles
Anticoagulants -- therapeutic use
Aryl Hydrocarbon Hydroxylases -- genetics
Cytochrome P-450 CYP2C9
Female
Follow-Up Studies
Gene Frequency -- genetics
Genotype
Humans
Male
Middle Aged
Mixed Function Oxygenases -- genetics
Polymorphism, Single Nucleotide -- genetics
Prevalence
Turkey
Vitamin K Epoxide Reductases

Online resources:

Available from publisher's website

In: Molecular biology reports vol. 39

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

The prevalence of VKORC1 1639 G>A and CYP2C923 genotypes in patients that requiring anticoagulant therapy in Turkish population.

APA

Silan C., Dogan O. T., Silan F., Kukulguven F. M., Asgun H. F., Ozdemir S., Uludag A., Atik S., Gungor B., Akdur S., Aksulu H. E. & Ozdemir O. (20130404). The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population. : Molecular biology reports.

Chicago

Silan Coskun, Dogan Omer Tamer, Silan Fatma, Kukulguven Fatma Mutlu, Asgun Halil Fatih, Ozdemir Semra, Uludag Ahmet, Atik Sinem, Gungor Buket, Akdur Seçil, Aksulu Hakki Engin and Ozdemir Oztürk. 20130404. The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population. : Molecular biology reports.

Harvard

Silan C., Dogan O. T., Silan F., Kukulguven F. M., Asgun H. F., Ozdemir S., Uludag A., Atik S., Gungor B., Akdur S., Aksulu H. E. and Ozdemir O. (20130404). The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population. : Molecular biology reports.

MLA

Silan Coskun, Dogan Omer Tamer, Silan Fatma, Kukulguven Fatma Mutlu, Asgun Halil Fatih, Ozdemir Semra, Uludag Ahmet, Atik Sinem, Gungor Buket, Akdur Seçil, Aksulu Hakki Engin and Ozdemir Oztürk. The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population. : Molecular biology reports. 20130404.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC

The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population. [electronic resource]

The prevalence of VKORC1 1639 G>A and CYP2C923 genotypes in patients that requiring anticoagulant therapy in Turkish population. [electronic resource]